Rankings
Pricing
Log In
Free Trial
US-listed companies
PURPLE BIOTECH LTD.
PURPLE BIOTECH LTD.
PPBT
Market cap
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Research and development expenses
3
7
12
16
17
Sales, general and administrative expenses
6
6
6
6
5
Operating Loss
8
14
18
23
-
Operating Loss
-7
-13
-
-
-22
Expenses on account of warrants
-
-16
-
-
-
Change in fair value of warrants
2
-
-
-
-3
Finance expenses
0
0
0
0
-2
Finance income
0
0
0
1
-1
Finance expenses (income), net
-
-
-0
-1
-
Finance income, net
-
-
-
-
-2
Loss for the year from continuing operations
-6
-28
-18
22
20
Loss from discontinued operation
-
-
-1
-
-
Loss for the year
6
28
18
22
20
Loss from cash flow hedges
-
-
-
0
-
Loss (profit) from cash flow hedges
-
-
-
-
-0
Total comprehensive loss for the year
-
-
-
22
-
Total comprehensive loss for the year
-6
-
-
-
20
Owners of the Company
6
28
18
22
20
Non-controlling interests
0
0
0
0
0
Total Loss attributable
-
-
18
22
-
Loss for the year
6
28
18
22
20
Owners of the Company
6
-
-
22
20
Non-controlling interests
0
-
-
0
0
Total comprehensive loss
-
-
-
22
-
Owners of the Company
6
-
-
22
20
Non-controlling interests
0
-
-
0
0
Total comprehensive loss for the year
-6
-
-
-
20
Basic loss per ADS - USD (in Dollars per share)
-
-
1.01
1.2
-
Basic loss per ADS - USD (in Dollars per share)
-
-
-
-
0.9
Number of ADSs used in calculating basic loss per ADS (in Dollars per share)
-
-
-
-
22
Basic loss (profit) per ADS – USD (in Dollars per share)
-
-
0.04
-
-